Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques Genest

Showing results (161-170 of 214) with videos related to

Pageof 22
Sort By:
JACC. Basic to Translational Science|August 1, 2018
Lipoprotein(a) Induces Human Aortic Valve Interstitial Cell CalcificationBin Yu, Anouar Hafiane, George Thanassoulis, et al.
The Canadian Journal of Cardiology|November 26, 2013
Diagnosis, prevention, and management of statin adverse effects and intolerance: Canadian Working Group Consensus updateG B John Mancini, A Yashar Tashakkor, Steven Baker, et al.
The American Journal of Cardiology|January 12, 2005
Reaching recommended lipid and blood pressure targets with amlodipine/atorvastatin combination in patients with coronary heart diseaseJean-Francois Dorval, Todd Anderson, Jean Buithieu, et al.
Journal of Clinical Lipidology|April 28, 2018
Posttranslational modification of proprotein convertase subtilisin/kexin type 9 is differentially regulated in response to distinct cardiometabolic treatments as revealed by targeted proteomicsMarie-Soleil Gauthier, Zuhier Awan, Annie Bouchard, et al.
Journal of the American College of Cardiology|June 2, 2010
RVX-208: a small molecule that increases apolipoprotein A-I and high-density lipoprotein cholesterol in vitro and in vivoDana Bailey, Ravi Jahagirdar, Allan Gordon, et al.
Circulation. Cardiovascular Genetics|December 25, 2009
Genetic variation at the proprotein convertase subtilisin/kexin type 5 gene modulates high-density lipoprotein cholesterol levelsIulia Iatan, Zari Dastani, Ron Do, et al.
Current Vascular Pharmacology|August 28, 2015
Identification and Treatment of Patients with Homozygous Familial Hypercholesterolaemia: Information and Recommendations from a Middle East Advisory PanelAbdullah Al-Ashwal, Fahad Alnouri, Hani Sabbour, et al.
International Journal of Cardiology|December 13, 2005
Can combining different risk interventions into a single formulation contribute to improved cardiovascular disease risk reduction? Rationale and design for an international, open-label program to assess the effectiveness of a single pill (amlodipine/atorvastatin) to attain recommended target levels for blood pressure and lipids (The JEWEL Program)F D Richard Hobbs, Gianfranco Gensini, G B John Mancini, et al.
Cytokine|September 29, 2009
Mid-trimester maternal plasma cytokines and CRP as predictors of spontaneous preterm birthMichael S Kramer, Susan R Kahn, Robert W Platt, et al.
Epidemiology (Cambridge, Mass.)|July 2, 2009
Antioxidant vitamins, long-chain fatty acids, and spontaneous preterm birthMichael S Kramer, Susan R Kahn, Robert W Platt, et al.
Pageof 22

Showing results (161-170 of 214) with videos related to

Sort By:
Pageof 22
JACC. Basic to Translational Science|August 1, 2018
Lipoprotein(a) Induces Human Aortic Valve Interstitial Cell CalcificationBin Yu, Anouar Hafiane, George Thanassoulis, et al.
The Canadian Journal of Cardiology|November 26, 2013
Diagnosis, prevention, and management of statin adverse effects and intolerance: Canadian Working Group Consensus updateG B John Mancini, A Yashar Tashakkor, Steven Baker, et al.
The American Journal of Cardiology|January 12, 2005
Reaching recommended lipid and blood pressure targets with amlodipine/atorvastatin combination in patients with coronary heart diseaseJean-Francois Dorval, Todd Anderson, Jean Buithieu, et al.
Journal of Clinical Lipidology|April 28, 2018
Posttranslational modification of proprotein convertase subtilisin/kexin type 9 is differentially regulated in response to distinct cardiometabolic treatments as revealed by targeted proteomicsMarie-Soleil Gauthier, Zuhier Awan, Annie Bouchard, et al.
Journal of the American College of Cardiology|June 2, 2010
RVX-208: a small molecule that increases apolipoprotein A-I and high-density lipoprotein cholesterol in vitro and in vivoDana Bailey, Ravi Jahagirdar, Allan Gordon, et al.
Circulation. Cardiovascular Genetics|December 25, 2009
Genetic variation at the proprotein convertase subtilisin/kexin type 5 gene modulates high-density lipoprotein cholesterol levelsIulia Iatan, Zari Dastani, Ron Do, et al.
Current Vascular Pharmacology|August 28, 2015
Identification and Treatment of Patients with Homozygous Familial Hypercholesterolaemia: Information and Recommendations from a Middle East Advisory PanelAbdullah Al-Ashwal, Fahad Alnouri, Hani Sabbour, et al.
International Journal of Cardiology|December 13, 2005
Can combining different risk interventions into a single formulation contribute to improved cardiovascular disease risk reduction? Rationale and design for an international, open-label program to assess the effectiveness of a single pill (amlodipine/atorvastatin) to attain recommended target levels for blood pressure and lipids (The JEWEL Program)F D Richard Hobbs, Gianfranco Gensini, G B John Mancini, et al.
Cytokine|September 29, 2009
Mid-trimester maternal plasma cytokines and CRP as predictors of spontaneous preterm birthMichael S Kramer, Susan R Kahn, Robert W Platt, et al.
Epidemiology (Cambridge, Mass.)|July 2, 2009
Antioxidant vitamins, long-chain fatty acids, and spontaneous preterm birthMichael S Kramer, Susan R Kahn, Robert W Platt, et al.
Pageof 22